ACCME to Senate Aging: conflict cop is on the beat

Share this article:

The ACCME submitted additional testimony to the Senate Special Committee on Aging, pushing back against the notions that the boundary between promotion and education in CME is poorly policed and that commercial support could easily be eliminated from CME.

Those perceptions were espoused frequently by CME industry critics at the committee's July 29 hearing, revealingly titled “Medical Education: Higher Learning or Higher Earning?”

In response, ACCME wrote: “For two decades, accreditation requirements have specifically addressed the separation of promotion from education.” The accrediting body noted that its Standards for Commercial Support, in place since 1992 and expanded in 2004, address the issue. The ACCME took issue with characterizations of an Institute of Medicine committee report. The report, “did not find evidence to support the concept that commercial support of continuing medical education results in bias in accredited continuing medical education,” said ACCME.

Calls to eliminate commercial support of CME fail to account for the complexity of CME funding, said ACCME.

“Although it may seem beneficial to completely eliminate this source of funding, many accredited providers and physician learners use this funding for education that could not otherwise be developed,” said the accreditor.

ACCME CEO Murray Kopelow defended ACCME and CME at the hearing as speaker after speaker portrayed the accrediting body as a toothless watchdog. Kopelow responded that critics' views of CME were outdated and that the lax practices they portrayed were of “another time and another place.”
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"